UCLA Duchenne muscular dystrophy research receives grant from California’s stem cell agency
UCLA life scientist April Pyle– and colleagues Melissa Spencer and Huan Meng– received $2.15 million from the California Institute for Regenerative Medicine to develop a stem cell gene editing technology called CRISPR/Cas9 to correct the genetic mutations that cause Duchenne.